Generated: October 20, 2017
DrugPatentWatch Database Preview
RANITIDINE HYDROCHLORIDE Drug Profile
What is the patent landscape for Ranitidine Hydrochloride, and what generic Ranitidine Hydrochloride alternatives are available?
is a drug marketed by Ranbaxy, Wockhardt, Apotex Inc, Bio Pharm Inc, Pharm Assoc, Dr Reddys Labs Inc, Amneal Pharms, Strides Pharma, Watson Labs, Sandoz, Aurobindo Pharma Ltd, Mylan, Actavis Mid Atlantic, Amneal Pharms Ny, Watson Labs Inc, Perrigo R And D, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Tolmar, Teva, West-ward Pharms Int, Boehringer Ingelheim, Bedford, Ivax Sub Teva Pharms, Mylan Labs Ltd, Taro, Hi Tech Pharma, Apotex, Par Pharm, Breckenridge Pharm, Silarx, Vintage Pharms, Nostrum Labs Inc, Contract Pharmacal, and Perrigo. and is included in sixty-one NDAs.
The generic ingredient in RANITIDINE HYDROCHLORIDE is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-three suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for Tradename: RANITIDINE HYDROCHLORIDE
Pharmacology for Tradename: RANITIDINE HYDROCHLORIDE
|SYRUP;ORAL||078684-001||Aug 27, 2009||AA||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||074552-002||Jul 30, 1998||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
Sun Pharm Inds Ltd
|TABLET;ORAL||075439-001||Apr 19, 2000||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
West-ward Pharms Int
|INJECTABLE;INJECTION||077458-001||Feb 16, 2006||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||075167-001||May 4, 2000||OTC||No||No||► Subscribe||► Subscribe||► Subscribe|
|CAPSULE;ORAL||074655-001||Oct 22, 1997||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||076760-001||Feb 24, 2006||OTC||No||No||► Subscribe||► Subscribe||► Subscribe|
|INJECTABLE;INJECTION||074764-001||Nov 19, 2004||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe|
|TABLET;ORAL||074467-001||Aug 29, 1997||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe|
Perrigo R And D
|TABLET;ORAL||091429-002||May 11, 2011||OTC||No||No||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.